Friday, November 22, 2024
Outside of a personal residence, real estate is an asset class that often is underrepresented in investor portfolios. One reason is that it takes a lot of capital or taking on a lot of debt to buy an apartment building, office building, or a farm. Real estate investment trusts (REITs) offer a stock exchange-traded way […]
With two current themes impacting school safety, one the COVID-19 pandemic and a call in some school districts to remove police officers from schools, Motorola Solutions (MSI) is working to improve school safety. MSI has teamed with SaferWatch to implement a security system that provides schools with a “mobile panic button” that can be used […]
The S&P 500, and its ETF analogue SPY, is roughly breakeven for the year, which is crazy if you think about it. We had a full market crash in March due to the coronavirus pandemic. For the most part, the concerns that arose in March haven’t come close to being resolved; yet the stock market […]
For nearly two years, gold’s been on quite a run. In fact, the precious metal is getting close to an all-time high. That hasn’t happened in nearly a decade. Investing in gold is a tricky business. Historically it seems that gold likes to run one of two ways: it’s either very hot or very cold, […]
Pfizer (PFE) just announced the U.S. government will pay $1.95 billion for PFE to produce and deliver 100 million doses of its COVID vaccine once the U.S. declares it’s safe and effective. Under the agreement, the U.S. can acquire an additional 500 million doses from PFE. “Through Operation Warp Speed, we are assembling a portfolio of vaccines […]
The 2020 second-quarter earnings season promises to be full of surprises – both positive and negative. Shareholders of stocks in index funds like SPY, DIA, and QQQ may be in for a rougher ride than they’d normally expect. With a large portion of the U.S. economy, including companies in SPY, DIA, and QQQ, shut down […]
Owens & Minor (OMI) had been flying under Wall Street’s radar until it preannounced earnings this week. The medical supplies provider told the market it is essentially doubling its previous adjusted net income guidance. OMI raised projections for net income from $0.50 to $0.60 for the year to between $1.00 and $1.20. OMI said it […]
Electric vehicles have been all the rage lately in the stock and options market. NIO (NIO) has been no exception to this. The company is sometimes called the “Tesla of China” and actually has $1 billion worth of sales already. However, the huge run up in the stock price gave NIO an extremely high valuation, […]
Let’s dream for a moment. It’s November 2021. A coronavirus vaccine for was found in late December 2020. Due to pre-ramping of production facilities, 100% of the U.S. population has been vaccinated. COVID-19 is no more. Given this possible reality, where are you going to do your holiday shopping? Are you geared up for Black […]
Since bottoming out in March 2020, Fate Therapeutics (FATE) has run from a low of $19.91 to a current price of $35.50 with plenty of catalysts. For one, FATE just entered into an exclusive license agreement with Baylor College of Medicine covering alloimmune defense receptors, a first-in-class approach that renders off-the-shelf allogeneic cell products resistant […]
